ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

49,565Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 1031

$2.25M Total Retail Price of All Prescriptions

Rank: 7 out of 1031

1,175 Patients Receiving at Least One Drug in Part D
68% Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Alabama
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

13% of this provider’s 1,175 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

35% of this provider’s 1,175 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 2,824 1,763 372 S3 1 1
FUROSEMIDE 1,757 1,552 264 2 7
LEVOTHYROXINE SODIUM 1,367 1,099 188 3 3
OMEPRAZOLE 1,220 832 223 4 2
LISINOPRIL 1,174 859 190 5 6
ALPRAZOLAM 1,084 604 195 B 6 12
SIMVASTATIN 1,029 770 173 7 4
POTASSIUM CHLORIDE 1,027 905 166 8 13
TRAMADOL HCL 943 670 179 9 15
GABAPENTIN 899 533 143 10 11
METFORMIN HCL 897 562 133 11 8
AMLODIPINE BESYLATE 814 646 126 12 5
METOPROLOL SUCCINATE 704 530 103 13 21
TRAZODONE HCL 694 498 126 14 32
WARFARIN SODIUM 681 577 83 15 27
MELOXICAM 664 477 117 16 16
CLOPIDOGREL 649 557 98 17 25
CLONAZEPAM 562 327 83 B 18 29
PRAVASTATIN SODIUM 554 314 103 19 10
SERTRALINE HCL 551 406 86 20 30
METOPROLOL TARTRATE 527 483 78 21 22
HYDROCHLOROTHIAZIDE 526 349 93 22 14
DONEPEZIL HCL 524 476 73 23 41
CITALOPRAM HBR 490 236 80 24 18
MIRTAZAPINE 472 451 78 25 59
ATORVASTATIN CALCIUM 456 301 81 26 9
LORAZEPAM 438 323 73 B 27 31
LISINOPRIL-HYDROCHLOROTHIAZIDE 429 262 60 28 23
NAMENDA 363 352 58 29 45
PANTOPRAZOLE SODIUM 356 295 86 30 24
NEXIUM 352 221 62 31 26
LANTUS 330 268 45 32 85
QUETIAPINE FUMARATE 326 247 46 A 33 60
ESCITALOPRAM OXALATE 325 205 63 34 43
CARVEDILOL 323 244 53 35 17
TAMSULOSIN HCL 316 270 47 36 33
OXYCODONE HCL-ACETAMINOPHEN 315 136 60 S2 37 92
ALLOPURINOL 312 288 59 38 35
LOSARTAN POTASSIUM 308 255 54 39 19
ATENOLOL 307 227 46 40 28
PROAIR HFA 306 115 112 41 42
AMITRIPTYLINE HCL 303 168 45 R 42 54
SPIRONOLACTONE 294 242 41 43 77
RANITIDINE HCL 279 159 49 44 44
CARBIDOPA-LEVODOPA 262 262 38 45 133
ROPINIROLE HCL 262 186 43 45 76
CYCLOBENZAPRINE HCL 251 80 69 R 47 51
GLIMEPIRIDE 249 217 32 48 40
ADVAIR DISKUS 241 163 66 49 70
LYRICA 241 119 37 49 49
MONTELUKAST SODIUM 236 151 37 51 38
ZOLPIDEM TARTRATE 234 116 43 52 20
ALENDRONATE SODIUM 225 202 40 53 65
PROMETHAZINE HCL 224 74 82 R 54 67
CYMBALTA 223 116 33 55 50
GLIPIZIDE 213 164 39 56 63
SPIRIVA 213 109 50 56 68
RISPERIDONE 204 154 31 A 58 100
FLUTICASONE PROPIONATE 188 134 55 59 39
CEFTRIAXONE* 185 180* 75 60 207
PREDNISONE 178 123 42 61 47
FENTANYL 176 144 26 S2 62 108
OXYBUTYNIN CHLORIDE 176 149 30 62 134
LIDOCAINE HCL* 175 170* 73 64 233
ISOSORBIDE MONONITRATE ER 174 139 25 65 80
TIZANIDINE HCL 173 97 37 66 61
PAROXETINE HCL 172 86 28 67 64
FLUOXETINE HCL 170 112 28 68 56
CIPROFLOXACIN HCL 162 138 102 69 53
SULFAMETHOXAZOLE-TRIMETHOPRIM 162 116 105 69 69
CRESTOR 159 118 29 71 36
PIOGLITAZONE HCL 154 121 23 R 72 93
ALBUTEROL SULFATE 150 130 75 73 173
ZETIA 150 89 28 73 78
AZITHROMYCIN 148 90 125 75 46
NOVOLOG 147 142* 27 76 164
ENALAPRIL MALEATE 141 113 22 77 66
LEVOFLOXACIN 139 115 99 78 58
BENAZEPRIL HCL 133 105 22 79 71
PREMARIN 133 80 27 R 79 122
AMPHETAMINE SALT COMBO 132 <11 17 S2 81 200
LEVETIRACETAM 131 96 15 82 126
NITROFURANTOIN* 129 98 27 83 202
NABUMETONE 129 94 35 83 179
FENOFIBRATE* 127 73 16 85 55
IBUPROFEN 126 45 31 86 99
IPRATROPIUM BROMIDE 126 121* 68 86 239
ACETAMINOPHEN-CODEINE 125 97 41 S3 88 127
LOSARTAN-HYDROCHLOROTHIAZIDE 123 91 25 89 37
QUINAPRIL HCL 121 83 14 90 128
VENLAFAXINE HCL ER 121 77 19 90 104
SYMBICORT 121 74 29 90 150
METOCLOPRAMIDE HCL 120 74 28 93 111
CLONIDINE HCL 119 87 39 94 34
AMIODARONE HCL 118 113* 19 95 160
BACLOFEN 118 80 19 95 114
MECLIZINE HCL 116 91 32 97 84
GEMFIBROZIL 115 57 17 98 112
NAPROXEN 115 90 37 98 88
EXELON 115 102 21 98 116
CELEBREX 114 82 22 101 89
JANUVIA 111 79 18 102 72
DIOVAN 110 76 16 103 81
METOLAZONE 110 75 20 103 189
PRIMIDONE 110 91 14 103 218
PROPRANOLOL HCL 108 53 17 106 143
CARISOPRODOL 107 <11 17 R 107 91
FENOFIBRATE* 106 74 15 108 55
TRIAMTERENE-HCTZ 104 99* 20 109 57
ONDANSETRON HCL* 104 59 38 109 147
VENTOLIN HFA 103 59 49 111 182
CILOSTAZOL 102 97* 14 112 238
METHOCARBAMOL 101 36 36 R 113 90
TORSEMIDE 100 79 14 114 144
OXYCODONE-ACETAMINOPHEN 100 89 15 S2 114 169
KLOR-CON M20 99 60 25 116 73
SUCRALFATE 99 71 24 116 138
NYSTATIN 98 82 56 118 155
PRAMIPEXOLE DIHYDROCHLORIDE 93 66 15 119 130
HYDROXYZINE HCL 92 58 25 R 120 148
BUSPIRONE HCL 91 23 17 121 107
LACTULOSE 91 86* 21 121 175
BYSTOLIC 90 43 13 123 125
FLUCONAZOLE 89 50 59 124 102
AMOX TR-POTASSIUM CLAVULANATE 88 46 65 125 117
VENLAFAXINE HCL 85 39 18 126 220
VESICARE 85 72 16 126 154
VERAPAMIL ER 84 66 15 128 96
MORPHINE SULFATE ER 83 35 14 S2 129 141
METFORMIN HCL ER 81 51 15 130 48
DIVALPROEX SODIUM ER 80 75* 19 131 194
PHENYTOIN SODIUM EXTENDED 79 <11 <11 132 131
DIAZEPAM 77 64 16 B 133 74
LOVAZA 76 <11 <11 134 140
DETROL LA 76 58 13 134 185
OXYCONTIN 76 <11 <11 S2 134 170
DICYCLOMINE HCL 75 45 22 137 213
OXYBUTYNIN CHLORIDE ER 75 70* 19 137 135
TOPIRAMATE 75 35 13 137 157
NYSTOP 75 70* 24 137 306
AMOXICILLIN 74 53 56 141 87
MORPHINE SULFATE 72 67* 36 S2 142 283
FINASTERIDE 72 67* 13 142 146
DIVALPROEX SODIUM 72 46 22 142 123
ZIPRASIDONE HCL 70 <11 <11 A 145 276
TIMOLOL MALEATE 69 <11 <11 146 331
CARBAMAZEPINE 69 <11 <11 146 222
NAMENDA XR 68 68 20 148 291
LATANOPROST 67 <11 <11 149 209
ETODOLAC 66 <11 <11 150 163
METHADONE HCL 66 <11 <11 S2 150 181
BUPROPION HCL SR 65 <11 20 152 172
EVISTA 65 <11 <11 152 174
GLYBURIDE-METFORMIN HCL 63 30 12 R 154 161
GLYBURIDE 62 34 14 R 155 121
DILTIAZEM ER 61 <11 <11 156 214
KLOR-CON 10 61 23 11 156 118
TEMAZEPAM 60 45 18 B 158 83
TERAZOSIN HCL 60 <11 <11 158 158
LAMOTRIGINE 60 <11 <11 158 230
GUANFACINE HCL 59 29 11 R 161 314
PHENOBARBITAL 58 <11 <11 R 162 224
DIGOX 57 <11 <11 163 103
OLANZAPINE 57 <11 <11 A 163 184
ONGLYZA 56 <11 <11 165 208
ABILIFY 56 <11 <11 A 165 178
NITROSTAT 56 38 32 165 268
LANTUS SOLOSTAR 55 39 13 168 106
FENOFIBRATE* 55 <11 <11 168 55
HUMALOG 53 41 16 170 171
AGGRENOX 53 <11 <11 170 239
DOXYCYCLINE HYCLATE 52 32 41 172 136
DALIRESP 52 22 12 172 335
AMLODIPINE BESYLATE-BENAZEPRIL 51 <11 <11 174 62
SEROQUEL XR 50 <11 <11 A 175 246
DIGOXIN 50 45* 11 175 165
MEGESTROL ACETATE 50 45* 29 R 175 190
FLUDROCORTISONE ACETATE 50 <11 <11 175 333
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 27, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.